R43OD020163 (HAN, XU)Jul 15, 2015 - Jan 14, 2017 NIH An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues Role: Principal Investigator |
|
R44OD020163 (HAN, XU)Aug 16, 2015 - Aug 31, 2021 NIH An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues Role: Principal Investigator |
|
(HAN, XU)Oct 1, 2015 - Feb 1, 2016 Coulter Foundation A Novel Device for Corneal Cryopreservation Role: Principal Investigator |
|
2018-00489 (HAN, XU)Jun 1, 2018 - Feb 1, 2020 NIFA A Highly Efficient Vitrification Device for Animal Embryos and Spermatozoa Role: Principal Investigator |
|
(HAN, XU)Aug 1, 2018 - Jan 1, 2020 Coulter Foundation Translation Research Partnership Frozen Heart: Development of Novel Organ Storage Media for Cardiac Transplantation Role: Principal Investigator |
|
R43OD026279 (HAN, XU)Aug 3, 2018 - Jan 31, 2021 NIH In-Situ Cryopreservation Without Cryoprotectants Role: Principal Investigator |
|
R43AI155070 (HAN, XU)May 12, 2020 - Apr 30, 2021 NIH A Novel Cryopreservation Technology for Large Skin Grafts to Facilitate Tissue Banking and Allograft Transplantations Role: Principal Investigator |
|
R44EY033254 (HAN, XU)Sep 1, 2021 - Aug 31, 2023 NIH Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback Role: Principal Investigator |
|
MB210106 (HAN, XU)Feb 1, 2022 Idea Development Award of 2022 MBRP Burn Program Role: Principal Investigator |
|
R44AI170389 (HAN, XU)May 6, 2022 - Apr 30, 2025 NIH Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology Role: Principal Investigator |
|
R44CA278579 (HAN, XU)Sep 15, 2022 - Aug 31, 2024 NIH Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products Role: Principal Investigator |
|
(HAN, XU)Jan 1, 2023 - Jan 1, 2025 Mid-American Transplant Clinical Innovation Award Establishment of the First Limbal Tissue Bank Based on the First-in-Class Biocompatible Cryopreservation Technology Role: Principal Investigator |
|
R44OD035392 (HAN, XU)Sep 15, 2024 - Aug 31, 2026 NIH Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery Role: Principal Investigator |
|
HT9425-24-1-1099 (Xu Han)Dec 1, 2024 - Dec 1, 2027 DoD Securing GMP Production and FDA Clearance for OdinSol as a First-in-Class Biocompatible Cryopreservation Technology to Innovate Blood Banking Role Description: Our first-in-class biocompatible cryopreservation medium has been modified to enhance the cryopreservation
efficiency of red blood cells, eliminating the need for toxic cell-permeating cryoprotectants and the complicated
operations required by traditional blood banking methods. This novel technology will offer cost-saving and
efficient options for improved supply chain management in the biobanking of red blood cell units. In this project,
we aim to obtain qualifications related to Good Manufacturing Practice (GMP) production, biocompatibility, safety,
and efficacy testing, and secure 510(k) clearance to pave the path to commercialization. Role: PI |